Testing PG-033 doses in healthy adults
Part of Skin clinical trials.
This Phase 1 study tests increasing doses of a new experimental drug (PG-033) in healthy people to understand how it works in the body and check for side effects. It helps researchers determine safe dosing before testing it in patients with medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old
- Have a healthy weight and body mass index (BMI) between 19.0 and 26.0)
- Pass all screening health tests (blood work, heart, ultrasound) with normal or non-concerning results
- Be willing to use reliable birth control and not donate eggs or sperm for 3 months after treatment
- Stop all medications, supplements, and certain foods (caffeine, alcohol, grapefruit) for the required time before and during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of a new medicine called PG-033 in healthy adults. It checks how the drug moves through the body and how food affects it, to find the safest starting dose for future studies.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests a new medicine called LH-001 in healthy volunteers to see if it is safe. You will receive either the medicine or a placebo (a dummy pill) and stay overnight for monitoring.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial tests an investigational drug in healthy people to see how safe it is and how the body processes it. It may help researchers decide if the drug should be studied further for a specific condition.
This trial is testing a new study drug called LAD106 to see if it is safe in healthy adults. It helps researchers learn how the drug works in the body before moving on to patients with a specific condition.
Hear when a new Lichen Simplex Chronicus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.